Thrasos Therapeutics Appoints Dr. Andreas Orfanos as Chief Medical Officer

Published: Sep 20, 2011

MONTREAL--(BUSINESS WIRE)--Thrasos, Inc. today announced the appointment of Dr. Andreas Orfanos, MBBCh, FFPM, as Chief Medical Officer. Dr. Orfanos has over 25 years of international experience in strategy development and executive and operational management in major healthcare sectors, with a particular focus on global pharmaceuticals and biotechnology.

Back to news